Class III beta-tubulin overexpression is a marker of poor clinical outcome in advanced ovarian cancer patients.
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Enrica Martinelli Amelia Paglia Cristiano Ferlini Simona Mozzetti Maria Gabriella Ferrandina Valerio Gallotta Giovanni Scambia |
| Publication date | May 1, 2006 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |